Angiozyme: Phase Ia and Ib

RZYM and partner Chiron Corp. (CHIR, Emeryville, Calif.) reported data from Phase Ia and Ib trials in a total of 30 healthy volunteers and cancer patients demonstrating that Angiozyme was well tolera...